Hayato Muranaka

Appearances

RESTRAINING PANCREATIC DUCTAL ADENOCARCINOMA PROGRESSION WITH CHOP DEPLETION IN PANCREATIC EPITHELIAL CELLS
Date
May 21, 2024
BACKGROUND: Obesity and type-2 diabetes mellitus (T2DM) are substantial risk factors for pancreatic ductal adenocarcinoma (PDAC). Both obesity and T2DM are often linked to aberrant insulin processing in β cells and altered liver lipid metabolism…
Presenter
Hayato Muranaka
Speakers
Jing Yong
Richard Waldron
Albert-Fred Aquino
Insook Jang
Randal Kaufman
Stephen Pandol
Cedars-Sinai Medical Center
Aurelia Lugea
NANOSTRING GEOMX SPATIAL TRANSCRIPTOMIC ANALYSIS OF PANCREATIC ISLETS IN DIABETIC AND NONDIABETIC PANCREATIC CANCER PATIENTS REVEALS BETA CELL DEDIFFERENTIATION ASSOCIATED WITH ER STRESS PATHWAYS AND ALTERED LIPID METABOLISM
Date
May 21, 2024
BACKGROUND: Pancreatic ductal adenocarcinoma (PC) is a deadly cancer with a rapidly rising incidence and a low 5-year relative survival rate…
Presenter
Richard Waldron
Speakers
Aurelia Lugea
Jing Yong
Hayato Muranaka
Mingtian Che
V. Krishnan Ramanujan
Mandar Muzumdar
Randal Kaufman
Stephen Pandol
Cedars-Sinai Medical Center